WASHINGTON (dpa-AFX) – ANI Pharmaceuticals, Inc. (ANIP) Wednesday reported profit of $9.53 million or $0.45 per share for the third quarter, compared with loss of $9.01 million or $0.55 per share in the same quarter a year ago, driven by growth in product sales. The company also raised its full-year…Read More
ANI Pharmaceuticals Turns To Q3 Profit Raises Fullyear Outlook
